Abstract:BACKGROUND:RNA N6-methyladenosine (m6A) has been found to have a critical impact on clear cell renal cell carcinoma (ccRCC) by affecting the tumor microenvironment (TME) and immune cell (IC) infiltration and is related to the treatment and survival rate of patients with ccRCC. However, the mechanism of m6A in TME and IC infiltration remained unclear.METHODS:Nonnegative Matrix Factorization (NMF) clustering was performed on 650 ccRCC cases from the Cancer Genome Atlas (TCGA) and the Gene-Expression Omnibus (GEO) datasets. The immune infiltration was generated by the single-sample gene-set enrichment analysis (ssGSEA) algorithm. Survival analyses were performed using the Kaplan-Meier method, and the significance of the differences was determined using the log-rank test. The m6A score was constructed based on the expression of m6A regulators to quantify m6A modification. The package "survminer R" was employed to layer patients' low and high scores groups and predict the immunotherapy response.RESULTS:Three different patterns of m6A modification were established, and significant differences in TME and IC infiltration features were found in these three patterns. Survival analysis demonstrated that m6A cluster A and m6A gene cluster A experienced a longer survival time. Evaluation of m6A modification patterns in individual tumors was initiated by the m6A score. The low m6A score subtype was characterized by increased tumor mutation burden (TMB) and immune infiltration, whereas a high m6A score with a lack of immune cell infiltration showed significantly better overall survival. m6A score was also associated with the expression of programmed cell death protein 1 (PD-L1) and cytotoxic T lymphocyte antigen 4 (CTLA-4). Patients in the high m6A score group had high PD-L1 expression and low CTLA-4 expression. Significant differences in prognosis were identified among types of different TMB and m6A scores, where low TMB and high m6A score had longer survival time.CONCLUSIONS:This research indicated that m6A modification greatly affected TME and IC infiltration. Physicians can develop practical immunotherapy strategies for patients with ccRCC by evaluating m6A-associated genes.

Additional File 4: of the M6a-Suppressed P2RX6 Activation Promotes Renal Cancer Cells Migration and Invasion Through ATP-induced Ca2+ Influx Modulating ERK1/2 Phosphorylation and MMP9 Signaling Pathway

The M6a-Suppressed P2RX6 Activation Promotes Renal Cancer Cells Migration and Invasion Through ATP-induced Ca2+ Influx Modulating ERK1/2 Phosphorylation and MMP9 Signaling Pathway.

Additional File 5 of Bladder Cancer-Derived Exosomal KRT6B Promotes Invasion and Metastasis by Inducing EMT and Regulating the Immune Microenvironment

Additional File 1 of Genetic Alterations and Functional Networks of M6a RNA Methylation Regulators in Pancreatic Cancer Based on Data Mining

Additional File 11: of A Positive Feed-Forward Loop Between LncRNA-URRCC and EGFL7/P-AKT/FOXO3 Signaling Promotes Proliferation and Metastasis of Clear Cell Renal Cell Carcinoma

Supplementary Data from mTOR Activation Initiates Renal Cell Carcinoma Development by Coordinating ERK and p38MAPK

MOESM6 of Exosomal Circrna-100338 Promotes Hepatocellular Carcinoma Metastasis Via Enhancing Invasiveness and Angiogenesis

Oncogenic Activation of AKT by MAPK6

Additional File 4: of A Positive Feed-Forward Loop Between LncRNA-URRCC and EGFL7/P-AKT/FOXO3 Signaling Promotes Proliferation and Metastasis of Clear Cell Renal Cell Carcinoma

Supplementary Figure 4 from CXCR6 Upregulation Contributes to a Proinflammatory Tumor Microenvironment That Drives Metastasis and Poor Patient Outcomes in Hepatocellular Carcinoma

P2X7 mediates ATP-driven invasiveness in prostate cancer cells.

Additional File 12: of Sunitinib-suppressed Mir-452-5p Facilitates Renal Cancer Cell Invasion and Metastasis Through Modulating SMAD4/SMAD7 Signals

Additional File 4 of the EGFR-HSF1 Axis Accelerates the Tumorigenesis of Pancreatic Cancer

MAPK6-AKT Signaling Promotes Tumor Growth and Resistance to Mtor Kinase Blockade

Additional File 12: of A Positive Feed-Forward Loop Between LncRNA-URRCC and EGFL7/P-AKT/FOXO3 Signaling Promotes Proliferation and Metastasis of Clear Cell Renal Cell Carcinoma

Comprehensive analysis of m6A methylome and transcriptome by Nanopore sequencing in clear cell renal carcinoma

A Signature Based on M6a Pattern and Tumor Microenvironment Infiltration in Clear Cell Renal Cell Carcinoma.

m6A Methylation Patterns and Tumor Microenvironment Infiltration Characterization in Clear-Cell Renal Cell Carcinoma

Extracellular ATP/P2X7 receptor, a regulatory axis of migration in ovarian carcinoma-derived cells

N6-Methyladenosine Regulator-Mediated Methylation Modification Patterns with Distinct Prognosis, Oxidative Stress, and Tumor Microenvironment in Renal Cell Carcinoma

Supplementary Data File from ATP-Citrate Lyase Epigenetically Potentiates Oxidative Phosphorylation to Promote Melanoma Growth and Adaptive Resistance to MAPK Inhibition